Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Prothena Corp
(NASDAQ:PRTA)
Intraday
$20.57
0
[0.00%]
After-Hours
$20.57
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$20.57
0
[0.00%]
At close: Apr 18
$20.57
0
[0.00%]
PreMarket: 4:00PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Prothena Corp Stock (NASDAQ:PRTA)
Prothena Corp Stock (NASDAQ: PRTA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, April 15, 2024
Prothena Announces Review On Birtamimab Mechanism Of Action And Pharmacological Characteristics Published In Leukemia & Lymphoma
Benzinga Newsdesk
-
3 days ago
Wednesday, April 10, 2024
Cantor Fitzgerald Reiterates Overweight on Prothena Corp
Benzinga Newsdesk
-
Apr 10, 2024, 1:26PM
Wednesday, March 13, 2024
Demystifying Prothena Corp: Insights From 8 Analyst Reviews
Benzinga Insights
-
Mar 13, 2024, 10:00AM
HC Wainwright & Co. Maintains Buy on Prothena Corp, Maintains $90 Price Target
Benzinga Newsdesk
-
Mar 13, 2024, 9:25AM
Thursday, February 29, 2024
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
-
Feb 29, 2024, 12:35PM
Friday, February 16, 2024
JMP Securities Maintains Market Outperform on Prothena Corp, Raises Price Target to $85
Benzinga Newsdesk
-
Feb 16, 2024, 2:58PM
Decoding 6 Analyst Evaluations For Prothena Corp
Benzinga Insights
-
Feb 16, 2024, 2:00PM
RBC Capital Maintains Sector Perform on Prothena Corp, Lowers Price Target to $35
Benzinga Newsdesk
-
Feb 16, 2024, 12:44PM
Thursday, February 15, 2024
Prothena Corp Q4 2023 GAAP EPS $(1.26) Misses $(1.22) Estimate, Sales $316.00K Miss $2.15M Estimate
Benzinga Newsdesk
-
Feb 15, 2024, 4:10PM
Prothena Corp: Q4 Earnings Insights
Benzinga Insights
-
Feb 15, 2024, 4:10PM
Earnings Scheduled For February 15, 2024
Benzinga Insights
-
Feb 15, 2024, 5:17AM
Wednesday, February 14, 2024
Earnings Outlook For Prothena Corp
Benzinga Insights
-
Feb 14, 2024, 11:02AM
Tuesday, January 30, 2024
Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
-
Jan 30, 2024, 1:18PM
Prothena shares are trading lower after B of A Securities downgraded the stock from Buy to Neutral and lowered its price target from $68 to $38.
Benzinga Newsdesk
-
Jan 30, 2024, 11:32AM
B of A Securities Downgrades Prothena Corp to Neutral, Lowers Price Target to $38
Benzinga Newsdesk
-
Jan 30, 2024, 8:06AM
Thursday, January 25, 2024
Navigating 5 Analyst Ratings For Prothena Corp
Benzinga Insights
-
Jan 25, 2024, 12:00PM
RBC Capital Maintains Sector Perform on Prothena Corp, Lowers Price Target to $36
Benzinga Newsdesk
-
Jan 25, 2024, 11:51AM
Monday, January 22, 2024
$100 Invested In Prothena Corp 5 Years Ago Would Be Worth This Much Today
Benzinga Insights
-
Jan 22, 2024, 3:31PM
Tuesday, January 09, 2024
Demystifying Prothena Corp: Insights From 5 Analyst Reviews
Benzinga Insights
-
Jan 9, 2024, 4:00PM
Cantor Fitzgerald Maintains Overweight on Prothena Corp, Lowers Price Target to $87
Benzinga Newsdesk
-
Jan 9, 2024, 9:08AM
Hewlett Packard Enterprise, Hologic And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Avi Kapoor
-
Jan 9, 2024, 6:36AM
Monday, January 08, 2024
Prothena shares are trading lower after the company provided a business update on portfolio programs.
Benzinga Newsdesk
-
Jan 8, 2024, 2:37PM
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
-
Jan 8, 2024, 1:36PM
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
-
Jan 8, 2024, 12:30PM
Boeing, Pacific Biosciences of California And Other Big Stocks Moving Lower On Monday
Avi Kapoor
-
Jan 8, 2024, 11:46AM
Prothena Provides Updates On PRX012, PRX123, Birtamimab and Portfolio Programs; Cash, Cash Equivalents And Restricted Cash ~$621M At 2023 Year End
Benzinga Newsdesk
-
Jan 8, 2024, 8:49AM
Monday, December 18, 2023
4 Analysts Have This to Say About Prothena Corp
Benzinga Insights
-
Dec 18, 2023, 10:00AM
Cantor Fitzgerald Reiterates Overweight on Prothena Corp, Maintains $129 Price Target
Benzinga Newsdesk
-
Dec 18, 2023, 9:57AM
Tuesday, November 21, 2023
Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others
Vandana Singh
-
Nov 21, 2023, 3:16PM
Tuesday, November 07, 2023
8 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
-
Nov 7, 2023, 12:35PM
Friday, November 03, 2023
JMP Securities Maintains Market Outperform on Prothena Corp, Lowers Price Target to $81
Benzinga Newsdesk
-
Nov 3, 2023, 3:48PM
Thursday, November 02, 2023
Prothena Q3 2023 EPS $(0.38) Misses $(0.32) Estimate, Revenue $84.9M
Benzinga Newsdesk
-
Nov 2, 2023, 4:56PM
Earnings Scheduled For November 2, 2023
Benzinga Insights
-
Nov 2, 2023, 4:56AM
Wednesday, November 01, 2023
Earnings Preview For Prothena Corp
Benzinga Insights
-
Nov 1, 2023, 11:01AM
Monday, October 23, 2023
Expert Ratings for Prothena Corp
Benzinga Insights
-
Oct 23, 2023, 11:00AM
Cantor Fitzgerald Reiterates Overweight on Prothena Corp, Maintains $129 Price Target
Benzinga Newsdesk
-
Oct 23, 2023, 10:15AM
Tuesday, October 17, 2023
Prothena Corporation shares are trading lower. The stock may be pulling back after gaining Monday on reports suggesting the company may be preparing for a potential sale.
Benzinga Newsdesk
-
Oct 17, 2023, 12:32PM
Monday, October 16, 2023
Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
-
Oct 16, 2023, 1:09PM
Lululemon, PCTEL, Consolidated Communications, Other Stocks Jumping Higher On Monday
Lisa Levin
-
Oct 16, 2023, 12:08PM
Prothena shares are trading higher following reports suggesting the company is talking to advisors, potentially preparing for a sale.
Benzinga Newsdesk
-
Oct 16, 2023, 11:32AM
Why Is Alzheimer's Player Prothena Stock Trading Higher Today?
Vandana Singh
-
Oct 16, 2023, 11:28AM
Reported Earlier, "Biotech Firm Prothena Prepares For Potential Sale" - Bloomberg
Benzinga Newsdesk
-
Oct 16, 2023, 10:47AM
Thursday, October 05, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Oct 5, 2023, 1:22PM
Tuesday, August 22, 2023
Expert Ratings for Prothena Corp
Benzinga Insights
-
Aug 22, 2023, 11:00AM
Cantor Fitzgerald Reiterates Overweight on Prothena Corp, Maintains $129 Price Target
Benzinga Newsdesk
-
Aug 22, 2023, 9:59AM
Friday, August 04, 2023
Prothena Corp shares are trading lower following worse-than-expected Q2 results.
Benzinga Newsdesk
-
Aug 4, 2023, 2:04PM
JMP Securities Maintains Outperform Rating for Prothena Corp: Here's What You Need To Know
Benzinga Insights
-
Aug 4, 2023, 1:00PM
HC Wainwright & Co. Reiterates Buy on Prothena Corp, Maintains $90 Price Target
Benzinga Newsdesk
-
Aug 4, 2023, 8:29AM
JMP Securities Maintains Outperform on Prothena Corp, Raises Price Target to $83
Benzinga Newsdesk
-
Aug 4, 2023, 7:57AM
Thursday, August 03, 2023
Prothena Corp Q2 EPS $(1.03) Misses $(1.00) Estimate, Sales $4.02M Miss $4.52M Estimate
Benzinga Newsdesk
-
Aug 3, 2023, 4:42PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch